Cogent Biosciences (COGT) Non Operating Income (2017 - 2026)
Cogent Biosciences (COGT) posted quarterly Non Operating Income of $6.3 million for Q1 2026, up 112.25% year-over-year from $2.9 million in Q1 2025, and up 308.57% quarter-over-quarter from -$3.0 million in Q4 2025.
Cogent Biosciences (COGT) Non Operating Income (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Non Operating Income for 10 consecutive years, with $6.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 112.25% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $7.7 million (down 59.23% YoY), while the FY2025 annual figure was $4.4 million, down 77.96% from the prior year.
- Non Operating Income improved to $6.3 million in Q1 2026 per COGT's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $6.3 million in Q1 2026 and bottomed at -$3.0 million in Q4 2025.
- Historically, Non Operating Income has averaged $3.2 million across 5 years, with a median of $3.9 million in 2023.
- Annual changes were most pronounced in 2023 — Non Operating Income surged 493.11% — and 2025, when it plunged 151.64%.
- Cogent Biosciences' Non Operating Income stood at $4.1 million in 2022, then dropped by 6.4% to $3.9 million in 2023, then jumped by 50.32% to $5.8 million in 2024, then slumped by 151.64% to -$3.0 million in 2025, then soared by 308.57% to $6.3 million in 2026.
- Business Quant data shows COGT's Non Operating Income at $6.3 million in Q1 2026, -$3.0 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | 6.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.23 Mn |
| Mar 31, 2026 | 6.26 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Sep 30, 2024 | 4.78 Mn |
| Jun 30, 2024 | 5.44 Mn |
| Mar 31, 2024 | 4.06 Mn |
| Dec 31, 2023 | 3.86 Mn |
| Sep 30, 2023 | 4.20 Mn |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | 4.65 Mn |
| Dec 31, 2022 | 4.13 Mn |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 928,000.00 |
| Mar 31, 2022 | 784,000.00 |
| Dec 31, 2021 | 728,000.00 |
| Sep 30, 2021 | 735,000.00 |